Related Experiment Video
Updated: Aug 9, 2025
06:09
Development of a Preclinical Inhalation Model to Test Vaporized Cannabis Distillates
Published on: May 30, 2025
243
Cannabis - a Rewritten History and Its Pulmonary Consequences
Florin Mihaltan1, Andrada Nechita1, Ancuta Constantin1
1"Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania.
Maedica
|February 23, 2023
Summary
Cannabis use poses significant respiratory health risks, including chronic bronchitis and cancer. Effective prevention strategies are crucial to mitigate these dangers.
Area of Science:
- Pharmacology and toxicology of cannabis.
- Epidemiology of cannabis use and associated health outcomes.
Background:
- Cannabis use is increasingly prevalent and a subject of ongoing scientific debate.
- Its respiratory effects are comparable to tobacco, leading to symptoms like chronic bronchitis and increased cancer risk.
Discussion:
- Review of cannabis pharmacology, epidemiology, and clinical impacts.
- Analysis of various prevention strategies for cannabis-related health issues.
Key Insights:
- Cannabis consumption presents numerous, often underestimated, health dangers.
- Understanding the drug's effects is vital for public health initiatives.
Outlook:
- Further research is needed to fully elucidate cannabis's long-term health consequences.
- Development and implementation of evidence-based prevention programs are essential.
Related Concept Videos
01:17Other Pulmonary Disorders
885
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
885
01:21Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
351
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
351
01:24CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
304
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
304
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
2.9K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.9K
01:22Chronic Obstructive Pulmonary Disease
1.4K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.4K
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.9K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.9K